Quest Diagnostics
DGX
#1095
Rank
โ‚น1.833 T
Marketcap
โ‚น16,396
Share price
-0.91%
Change (1 day)
23.90%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Quest Diagnostics (DGX) - Total assets

Total assets on the balance sheet as of September 2025 : โ‚น1.455 Trillion

According to Quest Diagnostics 's latest financial reports the company's total assets are โ‚น1.455 Trillion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Quest Diagnostics - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31โ‚น1.385 T18.71%
2023-12-31โ‚น1.167 T9.89%
2022-12-31โ‚น1.062 T4.85%
2021-12-31โ‚น1.013 T-1.24%
2020-12-31โ‚น1.025 T12%
2019-12-31โ‚น915.84 B19.04%
2018-12-31โ‚น769.35 B14.72%
2017-12-31โ‚น670.62 B-2.29%
2016-12-31โ‚น686.34 B3.67%
2015-12-31โ‚น662.02 B5.97%
2014-12-31โ‚น624.71 B13.01%
2013-12-31โ‚น552.80 B8.75%
2012-12-31โ‚น508.32 B3.18%
2011-12-31โ‚น492.67 B28.93%
2010-12-31โ‚น382.12 B-3.83%
2009-12-31โ‚น397.35 B-1.63%
2008-12-31โ‚น403.93 B20.16%
2007-12-31โ‚น336.16 B34.06%
2006-12-31โ‚น250.74 B5.01%
2005-12-31โ‚น238.77 B31.15%
2004-12-31โ‚น182.05 B-7.04%
2003-12-31โ‚น195.84 B22.86%
2002-12-31โ‚น159.41 B12.73%
2001-12-31โ‚น141.40 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
LabCorp
LH
โ‚น1.640 T 12.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
โ‚น0.74 B-99.95%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
โ‚น123.50 B-91.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
โ‚น5.70 B-99.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
โ‚น588.74 B-59.54%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands